In a recent video interview with Applied Clinical Trials, Jonathan Andrus, Co-CEO of CRIO, shares his perspective on how eClinical platforms will evolve in 2026 to strengthen data quality, oversight, and study efficiency. He discusses the growing shift toward protocol-driven eSource and site-based technologies that standardize data capture directly from the study protocol, ensuring consistency and compliance at the point of patient encounter. The conversation also explores the importance of cross-functional collaboration in protocol design, stronger data lifecycle governance, and the expanding role of AI in streamlining study build, data review, and operational workflows. Click below to read the full article to learn how these trends are shaping the future of clinical trial technology.